Group 4B: HER2 in all breast cancer subtypes; Racial Disparities



Friday, June 10
10:00 am – 11:30 am Eastern Time (US/New York)



Mentor: Lesley Kailani Glenn

Passion, motivation, and personal experience of living with metastatic breast cancer for the past 9 years drives Lesley’s desire to partner with communities, researchers and organizations, in aiding the funding of research for a cure, bringing awareness to this overlooked stage of breast cancer and support to those who live daily with Metastatic Breast Cancer. With a bachelor of science in organizational leadership, she has been actively involved in advocacy since 2015, training with the inaugural Hear My Voice Volunteer class presented by Living Beyond Breast Cancer. She was invited back as a mentor in 2018 and was awarded the Living Beyond Breast Cancer Leadership Volunteer Award in the Fall of the same year. She is the Co-Founder of the Annual Make Good Moves, Climb for a Cure that is held annually in Southern California, and Southern Oregon which funds research for a cure. She enjoys working with researchers and other stakeholders in the metastatic breast cancer field. She is a member of the Metastatic Breast Cancer Alliance, Susan G. Komen’s Advocates in Science, on the scientific advisory committee for the Love Research Army, and a consumer reviewer with the DOD-CDMRP.  She recently launched her biggest endeavor, Project Life, which is a virtual wellness house for those living with metastatic breast cancer and their loved ones. Lesley currently, lives in the Rogue Valley of Southern Oregon with her 2 rescue pups and 1 rescue cat who thinks he is one of the dogs.

Twitter: @LesleyKailani

Scientist: Amanda Jacobson, Ph.D.

Amanda Jacobson obtained a Ph.D. in cell biology and immunology from the University of Utah, and her post-doctoral work focused on HIV pathogenesis and infant immunology. She has been in the biotech/ pharma space supporting oncology drug development in both blood and solid tumor indications for a little over 10 years. Currently, she is the director of clinical science at a small biotech company supporting clinical trials in breast cancer.